首页 正文

Protective effect and molecular mechanisms of magnolol in ischemic stroke

{{output}}
The treatment methods for ischemic stroke (IS) are currently limited, posing a significant challenge to global healthcare. Tissue-type plasminogen activator remains the only effective drug for IS, yet its use is restricted by narrow therapeutic windows and pot... ...